You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
舒泰神(300204.SZ):醫藥產業園(I期)建設項目取得環境影響報吿書的批覆
格隆匯 01-25 16:48

格隆匯 1 月 25日丨舒泰神(300204.SZ)公佈,公司全資子公司四川舒泰神生物製藥有限公司(“舒泰神四川”)於近日取得了眉山市生態環境局簽發的《關於四川舒泰神生物製藥有限公司舒泰神醫藥產業園(I期)建設項目環境影響報吿書的批覆》(眉市環建函【202111號)。

根據批覆,項目嚴格按照《四川舒泰神生物製藥股份有限公司舒泰神產業園(I期)建設項目環境影響報吿書》中所列項目的性質、規模、工藝、地點和擬採取的生態環境保護措施建設和運行,對生態環境的不利影響能夠得到緩解和控制,因此,眉山市生態環境局原則同意報吿書結論。公司應全面落實報吿書提出的各項生態環境保護對策措施和批覆的要求。

舒泰神醫藥產業園(I期)建設項目主要建設重組蛋白/單克隆抗體、基因/細胞治療藥和化學仿製藥產品線。公司將督促相應實施主體按照環評批覆要求進行項目管理與運營,確保項目實施和環境保護的協調和可持續發展。

此次四川子公司取得該批覆,有助於基地建設的順利推進,符合公司長期戰略佈局,符合公司及全體股東的利益,對公司的財務狀況及經營業績不會造成重大影響。敬請廣大投資者謹慎決策投資,注意投資風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account